Alterity Therapeutics (ATHE) Operating Leases (2019 - 2025)

Alterity Therapeutics has reported Operating Leases for 7 years, with the latest figure at $42980.1 in Q4 2025.

• For the quarter ending Q4 2025, Operating Leases changed N/A year-over-year to $42980.1; the trailing twelve-month figure through Dec 2025 stood at $42980.1 (changed N/A YoY), and the FY2025 full-year result was $56707.2, up 65.75% from the prior year.
• Operating Leases for Q4 2025 stood at $42980.1, down from $56707.2 in the prior quarter.
• The five-year high for Operating Leases was $56707.2 in Q2 2025, with the low at $1071.3 in Q2 2024.
• Average Operating Leases over 5 years is $28981.9, with a median of $36030.5 recorded in 2021.
• Year-over-year, Operating Leases tumbled 97.5% in 2023 and surged 5193.25% in 2025.
• Tracing ATHE's Operating Leases over 5 years: stood at $29187.4 in 2021, then surged by 46.89% to $42873.7 in 2022, then plunged by 97.5% to $1071.8 in 2023, then fell by 0.04% to $1071.3 in 2024, then soared by 3911.92% to $42980.1 in 2025.
• The last three Operating Leases figures came in at $42980.1 (Q4 2025), $56707.2 (Q2 2025), and $1071.3 (Q2 2024), per Business Quant data.

Peer Comparison